Hybrid Conference (In Person / Virtual)

International Conference on Antiretroviral Therapy, Clinical Trials, and Innovations (ICATCTI - 27)
25th - 26th March 2027 , Miami, USA
** Important Notice      Beware of fraudulent emails and calls impersonating IIRD Conference to collect conference and journal fees. Ensure all payments are processed only through our official event website. Report suspicious activity to [email protected].

Call For Papers

The ICATCTI provides a supportive platform for both experienced researchers and early-career academicians to present their work and gain recognition.

The conference covers diverse topics such as Hiv/aids, encouraging participation from emerging researchers and fostering academic growth.

Authors are invited to submit papers addressing, but not limited to, the following areas:

01
Innovations in Antiretroviral Therapy
02
Clinical Trials and Gender Perspectives
03
Impact of HIV on Gender Dynamics
04
Global Access to Antiretroviral Treatments
05
Gender and Health Disparities in HIV
06
Youth Engagement in HIV Research
07
Cultural Contexts of HIV Treatment
08
Intersectionality in Clinical Trials
09
Advocacy for HIV/AIDS Awareness
10
Gender and Stigma in HIV Care
11
Public Health Policies for HIV Prevention
12
Mental Health and HIV/AIDS
13
Global Perspectives on HIV Research
14
Community-Based Approaches to HIV Care
15
Future Directions in HIV Treatment
16
Gender and Sexual Health Education
17
Research Innovations in HIV Prevention
18
Gender-Sensitive Approaches to Care
19
Impact of COVID-19 on HIV Services
20
Gender and Access to Healthcare Resources

Assessment

Submissions will be reviewed to ensure quality and relevance, with a focus on encouraging emerging research contributions. Accepted papers will be presented and considered for publication opportunities.

Registration

Early-career researchers are encouraged to register and present their work, gaining valuable feedback and academic exposure.

Publication

The conference provides opportunities for emerging researchers to publish their work in recognized platforms.